Increased resistance to activated protein C and factor V Leiden in recurrent abortions. Review of other hypercoagulability factors

Eur J Contracept Reprod Health Care. 1999 Sep;4(3):135-44.

Abstract

Objective: To evaluate hereditary and acquired hemostatic abnormalities associated with recurrent spontaneous early (first-trimester) abortions.

Method: A group of 56 Greek women with two or more unexplained primary spontaneous abortions, and a reference group of 148 women without a history of recurrent abortions, were screened for hypercoagulability. A randomly selected population of first-trimester pregnant women was also chosen for factor V Leiden genetic screening.

Results: A total of 21% of the women with recurrent abortions, compared with 12% of the reference group, showed increased activated protein C resistance. Fourteen per cent had positive lupus anticoagulant, compared with 11.5% of the reference group. For the rest of the parameters, there was no difference between the two groups. Of 22 women studied for factor V Leiden, one was homozygous and one was heterozygous. Results were compared using Fisher's exact test and two-tailed Student's t tests.

Conclusions: Increased activated protein C resistance appears to be an important factor in women with recurrent abortions. These data indicate the need for routine investigation of activated protein C resistance in women with recurrent abortions.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Abortion, Spontaneous / blood
  • Abortion, Spontaneous / epidemiology
  • Abortion, Spontaneous / genetics*
  • Factor V / genetics*
  • Female
  • Genetic Testing
  • Humans
  • Mutation
  • Polymerase Chain Reaction
  • Pregnancy
  • Pregnancy Trimester, First
  • Probability
  • Protein C / genetics*
  • Recurrence
  • Reference Values
  • Risk Assessment
  • Thrombophilia / genetics*

Substances

  • Protein C
  • factor V Leiden
  • Factor V